Ferrologix is a scientific research and development company that provides cellular therapy and cell separation services.
Ferrologix was launched as a startup from the University of California Los Angeles emerging from professor Dino Di Carlo's lab in the department of bioengineering. It has a unique magnetic-based instrument and disposable cartridge that can transport, filter, and organize single cells for precision analysis or therapeutic manufacture. Pioneering a technique called Digital Magnetic Sorting, Ferrologix is developing a suite of tools to assist, accelerate, and scale the development of precision medicine research, next-gen diagnostics, and cellular therapies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 16, 2017 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |